D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

D₁/D₅ Dopamine Agonists as Pharmacotherapy for Schizophrenia

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English (US)
Title of host publication	Targets and Emerging Therapies for Schizophrenia
Publisher	John Wiley and Sons
Pages	51-84
Number of pages	34
ISBN (Print)	9780470322826
DOIs	https://doi.org/10.1002/9781118309421.ch3
State	Published - Jun 24 2012

@inbook{9bfa1059515b460ca4b3f6b9bf50ac60,

title = "D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia",

author = "Boyd, {Kevin N.} and Mailman, {Richard B.}",

year = "2012",

month = jun,

day = "24",

doi = "10.1002/9781118309421.ch3",

language = "English (US)",

isbn = "9780470322826",

pages = "51--84",

booktitle = "Targets and Emerging Therapies for Schizophrenia",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

AU - Boyd, Kevin N.

AU - Mailman, Richard B.

PY - 2012/6/24

Y1 - 2012/6/24

UR - http://www.scopus.com/inward/record.url?scp=84886109345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886109345&partnerID=8YFLogxK

U2 - 10.1002/9781118309421.ch3

DO - 10.1002/9781118309421.ch3

M3 - Chapter

AN - SCOPUS:84886109345

SN - 9780470322826

SP - 51

EP - 84

BT - Targets and Emerging Therapies for Schizophrenia

PB - John Wiley and Sons

ER -